Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Number of Clinical Trials Due to Rising Chronic Diseases and Lifestyle-related Disorders
4.2.2 Rise in Outsourcing of Clinical Trials and Implementation by Contract Research Organizations
4.3 Market Restraints
4.3.1 Data Security Issues
4.3.2 High Cost Associated With Clinical Trial Management Systems
4.4 Industry Attractiveness - Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Delivery Mode
5.1.1 On-premise
5.1.2 Cloud-based
5.2 By Component
5.2.1 Software
5.2.2 Services
5.3 By End User
5.3.1 Pharmaceuticals
5.3.2 Contract Research Organization
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ArisGlobal LLC
6.1.2 Bioclinica
6.1.3 DATATRAK International Inc.
6.1.4 Advarra
6.1.5 DZS Clinical Services
6.1.6 ERT Clinical
6.1.7 IBM
6.1.8 Dassault Syst?mes (Medidata Solutions Inc.)
6.1.9 MedNet Solutions Inc.
6.1.10 Oracle Corporation
6.1.11 Calyx
6.1.12 RealTime Software Solutions LLC
6.1.13 Veeva Systems


7 MARKET OPPORTUNITIES AND FUTURE TRENDS